Impact of the COVID-19 pandemic on patients receiving intravitreal injections

Impact of the COVID-19 pandemic on patients receiving intravitreal injections

We analyzed the economic benefits versus safety risks of sharing anti-vascular endothelial growth factor (VEGF) vials during the coronavirus disease (COVID-19) pandemic. This single-center retrospective study analyzed the data of patients with neovascular age-related macular degeneration (nAMD), pro...

Full description

Bibliographic Details
Main Authors:	Zhang Ningzhi, He Xuejun, Xing Yiqiao, Yang Ning
Format:	Article
Language:	English
Published:	University of Belgrade, University of Novi Sad 2022-01-01
Series:	Archives of Biological Sciences
Subjects:	anti-vascular endothelial growth factor (vegf) covid-19 intravitreal injection post-injection endophthalmitis vial splitting
Online Access:	http://www.doiserbia.nb.rs/img/doi/0354-4664/2022/0354-46642200003Z.pdf

Similar Items

Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
by: Vinicius Campos Bergamo, et al.
Published: (2023-09-01)

ANTISEPTICS AT INTRAVITREAL INJECTIONS
by: I. E. Ioshin, et al.
Published: (2016-11-01)

SAFETY OF INTRAVITREAL INJECTIONS
by: I. E. Ioshin
Published: (2017-10-01)

Changes in Aqueous Humor Cytokine Profile Following Intravitreal Brolucizumab Injection
by: Ruamviboonsuk V, et al.
Published: (2025-02-01)

Efficacy and safety of intravitreal injection of amikacin for endophthalmitis: a systematic review
by: ZiChao Ji, et al.
Published: (2023-07-01)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
by: Casey C. Bunge, MD, et al.
Published: (2023-12-01)

Bedside bilateral sequential intravitreal anti-VEGF injections for retinopathy of prematurity
by: Priya Bajgai, et al.
Published: (2025-01-01)

Posterior scleritis after biweekly aflibercept intravitreal injections
by: Mélanie Hébert, et al.
Published: (2022-12-01)

Topical Antibiotic Prophylaxis and Intravitreal Injections: Impact on the Incidence of Acute Endophthalmitis—A Nationwide Study in France from 2009 to 2018
by: Florian Baudin, et al.
Published: (2022-10-01)

Analysis of topical conjunctival microbiotic cultures in patients treated with intravitreal injections using antibiotic prophylaxis with 0.3% ofloxacin eye drops
by: Luca Bongiovanni de Miranda Gonçalves, et al.
Published: (2024-12-01)

The effect of diluting povidone-iodine on bacterial growth associated with speech
by: Sivashanth Gnanasekaran, et al.
Published: (2019-02-01)

Response to correspondence from Koerner and colleagues concerning our paper entitled: The effect of diluting povidone-iodine on bacterial growth associated with speech
by: Sivashanth Gnanasekaran, et al.
Published: (2020-08-01)

Morganella morganii and Enterococcus faecalis endophthalmitis following intravitreal injection
by: Michael Kvopka, et al.
Published: (2023-11-01)

Intravitreal injections: antibiotics or antiseptics?
by: I. E. Ioshin, et al.
Published: (2018-10-01)

Noninvasive method to reduce vitreous reflux following intravitreal injection
by: Raouf Gaber, et al.
Published: (2023-01-01)

Survey of Intravitreal Injection Techniques and Treatment Protocols Among Members of the Turkish Ophthalmological Association
by: Ecem Önder Tokuç, et al.
Published: (2021-12-01)

Case report: heart failure related to intravitreal injection of anti-VEGF
by: Yuying Sui, et al.
Published: (2024-08-01)

Intravitreal Injections and Face Masks: Endophthalmitis Risk Before and During the COVID-19 Pandemic
by: Saeed Karimi, et al.
Published: (2023-07-01)

Laser flare photometry: a cost-effective method for early detection of endophthalmitis after intravitreal injection of anti-VEGF agents
by: Vânia Lages, et al.
Published: (2018-12-01)

Effects of Intravitreal Injection of Ranibizumab and Aflibercept on Corneal Endothelium and Central Corneal Thickness
by: Mehmet Coskun
Published: (2018-08-01)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
by: Tyler A. Bahr, et al.
Published: (2023-04-01)

Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan
by: Amna Rizwan, et al.
Published: (2022-01-01)

Acute bacterial endophthalmitis following dexamethasone intravitreal implant: A case report
by: Waseem Al Zamil, et al.
Published: (2019-01-01)

Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
by: Caifeng Gao, et al.
Published: (2023-05-01)

Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
by: Ayşe Ergin, et al.
Published: (2022-12-01)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
by: Lima-Fontes M, et al.
Published: (2022-09-01)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
by: Tzu-Yi Lin, et al.
Published: (2023-02-01)

Clinical Characteristics and Outcomes of Endophthalmitis Before and During the COVID-19 Pandemic
by: Blake H Fortes, et al.
Published: (2023-07-01)

Liposomal Ozonated Oil Ensures a Further Reduction in the Microbial Load Before Intravitreal Injection: the “OPERA” Study
by: Maria Oliva Grassi, et al.
Published: (2024-08-01)

Cost-effectiveness of intravitreal therapy in Age-Related Macular Degeneration
by: Piergiorgio Neri, et al.
Published: (2014-12-01)

Two cases of diabetic macular edema with diminished areas of retinal non-perfusion and microaneurysms after intravitreal faricimab injections
by: Miki Sawa, et al.
Published: (2024-03-01)

Effects of Topical or Intravitreal Application of Anti-Vascular Endothelial Growth Factor on Density of Intestinal Blood Vessels of Mice
by: Atsushi Ichio, et al.
Published: (2023-04-01)

Triple Gram-negative bacterial endophthalmitis following intravitreal injection
by: Samy Zaher, et al.
Published: (2024-02-01)

Real-World-Data of Treatment-Naïve and Previously Treated Patients Receiving Up to 3 Injections of Faricimab in Neovascular Age-Related Macular Degeneration
by: Kunzmann BC, et al.
Published: (2024-12-01)

Randomized Clinical Trial of Intraocular Pressure-Lowering Medications on Preventing Spikes in Intraocular Pressure Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections
by: Piriya Soomsawasdi, et al.
Published: (2024-12-01)

Comparative Study on Anti-VEGF in Wet Age-Related Macular Degeneration in the Setting Based on Lean Methodology from the Bari Intravitreal Injection Registry (BIVIR)
by: Maria Oliva Grassi, et al.
Published: (2024-04-01)

The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
by: Fangyuan Han, et al.
Published: (2022-11-01)

Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
by: Pastor-Pascual F, et al.
Published: (2022-11-01)

Study of the Effectiveness of Precision Doses of Antibiotics in the Treatment of Induced Acute Bacterial Postoperative Endophthalmitis in an Experiment
by: V. N. Kazajkin, et al.
Published: (2019-12-01)

Clinico-etiological profile and drug sensitivity patterns in endophthalmitis due to Bacillus species: A case series
by: Pradeep Kumar Panigrahi, et al.
Published: (2021-01-01)